Cyclerion Therapeutics Inc (OQ:CYCN)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for CYCN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 20th, 2021
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jun 7/21 Jun 3/21 Hecht Peter M Direct Ownership Common Stock P - Open market or private purchase 823,170 $3.28
Jun 7/21 Jun 3/21 Slate Path Capital LP Indirect Ownership Common Stock, no par value P - Open market or private purchase 961,538 $3.12
Jun 7/21 Jun 3/21 Mcguire Terrance Indirect Ownership Common Stock P - Open market or private purchase 3,322 $3.12
Jun 7/21 Jun 3/21 Mcguire Terrance Indirect Ownership Common Stock P - Open market or private purchase 92,831 $3.12
May 19/21 May 19/21 Desouza Errol B Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
May 10/21 May 6/21 Hecht Peter M Direct Ownership Common Stock P - Open market or private purchase 302,000 $2.43
May 6/21 May 5/21 Hecht Peter M Direct Ownership Common Stock P - Open market or private purchase 398,001 $2.53
May 6/21 May 4/21 Hecht Peter M Direct Ownership Common Stock P - Open market or private purchase 300,000 $2.29
Mar 1/21 Feb 25/21 Gjino Anjeza Direct Ownership Common Stock S - Open market or private sale -1,824 $4.00
Mar 1/21 Feb 25/21 Wright Christopher I Direct Ownership Common Stock S - Open market or private sale -2,637 $3.99
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for CYCN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 20th, 2021
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jun 7/21 Jun 3/21 Hecht Peter M Direct Ownership Common Stock P - Open market or private purchase 823,170 $3.28
Jun 7/21 Jun 3/21 Slate Path Capital LP Indirect Ownership Common Stock, no par value P - Open market or private purchase 961,538 $3.12
Jun 7/21 Jun 3/21 Mcguire Terrance Indirect Ownership Common Stock P - Open market or private purchase 3,322 $3.12
Jun 7/21 Jun 3/21 Mcguire Terrance Indirect Ownership Common Stock P - Open market or private purchase 92,831 $3.12
May 19/21 May 19/21 Desouza Errol B Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
May 10/21 May 6/21 Hecht Peter M Direct Ownership Common Stock P - Open market or private purchase 302,000 $2.43
May 6/21 May 5/21 Hecht Peter M Direct Ownership Common Stock P - Open market or private purchase 398,001 $2.53
May 6/21 May 4/21 Hecht Peter M Direct Ownership Common Stock P - Open market or private purchase 300,000 $2.29
Mar 1/21 Feb 25/21 Gjino Anjeza Direct Ownership Common Stock S - Open market or private sale -1,824 $4.00
Mar 1/21 Feb 25/21 Wright Christopher I Direct Ownership Common Stock S - Open market or private sale -2,637 $3.99
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $CYCN

Competitors

Competitors with Recent Insider Filings
Syneos Health (OQ:SYNH)
Moderna (OQ:MRNA)
AbCellera Biologics (OQ:ABCL)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.